Haematological and radiological-based prognostic markers of COVID-19

Suliman A Alsagaby1, Abdulrhman Aljouie2, Talal H Alshammari3

  • 1Department of Medical Laboratories Sciences, College of Applied Medical Sciences, Majmaah University, AL-Majmaah 11932, Saudi Arabia.

Insights

Predicting COVID-19 mortality is crucial. Age, d-dimer, white blood cell counts, and chest X-ray scores are key indicators for patient survival and prognosis in coronavirus disease 2019.

Area of Science:

  • Medical research
  • Infectious diseases
  • Public health

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, presents a spectrum of illness severity, with moderate to fatal cases posing significant public health challenges.
  • Effective management and pandemic control rely on accurate prediction of patient prognosis.
  • Identifying biomarkers for COVID-19 mortality and overall survival (OS) is essential for clinical decision-making.

Purpose of the Study:

  • To identify biomarkers associated with COVID-19 mortality.
  • To determine predictors of overall survival (OS) in hospitalized COVID-19 patients.

Main Methods:

  • Retrospective analysis of clinical data from 6026 adult COVID-19 patients.
  • Data collected from two major centers in Saudi Arabia between April and June 2020.
  • Evaluation of various clinical, laboratory, and radiological markers, including d-dimer, WBC counts, neutrophil percentage, and chest X-ray (CXR) scores.

Main Results:

  • Over 23% mortality rate observed in the study cohort.
  • Significant mortality predictors identified: older age, elevated d-dimer, increased white blood cell (WBC) counts, higher neutrophil percentage, and higher CXR scores.
  • CXR scores demonstrated a positive correlation with age, d-dimer, WBC count, and neutrophil percentage, suggesting utility in the absence of blood tests.
  • RT-PCR Ct values were not successful in predicting mortality; quantitative RT-PCR is recommended.
  • Age, d-dimer concentration, leukocyte parameters, and CXR score were confirmed as prognostic markers for OS.

Conclusions:

  • Age, hematological parameters, and radiological findings at diagnosis are valuable for guiding clinical management of hospitalized COVID-19 patients.
  • These factors can aid in predicting prognosis and improving patient outcomes.
  • Further research into quantitative viral load assessment may enhance predictive accuracy.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
413
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
262
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K